Tourmaline Bio (TRML)
NASDAQ:TRML
US Market

Tourmaline Bio (TRML) Income Statement

Compare
517 Followers

Tourmaline Bio Income Statement

Last quarter (Q4 2024), Tourmaline Bio's total revenue was $40.00K, a decrease of -98.24% from the same quarter last year. In Q4, Tourmaline Bio's net income was $-22.23M. See Tourmaline Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -33.00K$ -6.00K$ -623.00K$ -447.00K
Operating Expenses
$ 89.73M$ 45.41M$ 19.70M$ 904.00$ 22.24M
Depreciation and Amortization
$ 0.00$ 33.00K$ 6.00K$ 904.00$ 447.00K
EBITDA
$ -89.73M$ -45.38M$ -19.70M$ -46.88M$ -22.24M
Operating Income
$ -89.73M$ -45.41M$ -19.70M$ -904.00$ -22.68M
Other Income/Expenses
$ 16.52M$ 3.29M$ 0.00$ -47.83M$ -23.00K
Pretax Income
$ -73.21M$ -42.12M$ -19.70M$ -904.00$ -22.71M
Net Income
$ -73.21M$ -42.12M$ -19.70M$ -904.00$ -22.71M
Per Share Metrics
Basic EPS
$ -2.89$ -8.87$ -0.97$ 0.00$ -33.97
Diluted EPS
$ -2.89$ -8.87$ -0.97$ 0.00$ -33.97
Weighted Average Shares Outstanding
25.35M 4.75M 20.34M 10.88M 668.51K
Weighted Average Shares Outstanding (Diluted)
25.35M 4.75M 20.34M 10.88M 668.51K
Currency in USD

Tourmaline Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis